NMTR News and Press, 9 Meters Biopharma Inc. From 03/30/21

9 Meters Biopharma (NMTR) has lost ~11.8% after announcing the commencement of a proposed underwritten public offering of common stock.Underwriters have a 30-day option to purchase up to an additional 15% of the shares to be sold in the offering.All the shares will be sold by 9 Mete...

RALEIGH, NC / ACCESSWIRE / March 30, 2021 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company focused on rare and unmet needs in gastroenterology, announced today that it has commenced a proposed underwritten public offering of shares of its common stock. In connection with th...

Shares of former penny stock ProQR Therapeutics ( NASDAQ: PRQR ) surged on Thursday morning. The company’s stock began the year at $4.25. It has now managed to reach highs of $9.44 on March 25th. The company specializes in transformative RNA therapies. Its QR-421a drug candid...

Frequency Therapeutics (FREQ) -71% after releases new data. from two FX-322 clinical studies; plans to advance single-dose regimen.Anixa Biosciences (ANIX) -23% after raises previously announced bought deal offering of common stock to $22.5M.Windtree Therapeutics (WIN...

9 Meters Biopharma (NMTR): Q4 GAAP EPS of -$0.03.As of December 31, 2020, the Company's cash and cash equivalents totaled approximately $37.9 million, compared to approximately $4.6 million on December 31, 2019. Additionally, $6.7 million in proceeds were received by the Company from warrant ...

FDA Type C meeting communications support plans to initiate Phase 2 in Q2 with NM-002 for short bowel syndrome (SBS) using Total Stool Output (TSO) as a primary efficacy outcome measure Announced positive topline data in December for NM-002, a proprietary long-acting GLP-1, in a Phase...

Tuesday, March 23 rd @ 11am Eastern Time RALEIGH, NC / ACCESSWIRE / March 15, 2021 / 9 Meters Biopharma (NASDAQ:NMTR), a clinical-stage rare and unmet needs-focused gastroenterology company, today announced that it will host a key opinion leader (KOL) webinar on short bowel syndrome (S...

- Oppenheimer 31 st Annual Healthcare Conference - March 16 th - 18 th - Maxim Group 2021 Emerging Growth Virtual Conference - March 17 th - 18 th RALEIGH, NC / ACCESSWIRE / March 10, 2021 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage rare and unmet nee...

RALEIGH, NC / ACCESSWIRE / March 9, 2021 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage rare and unmet needs-focused gastroenterology company, announced today that chief medical officer Patrick Griffin, M.D., FACP, will participate in an invited presentation at an upcoming virtua...

RALEIGH, NC / ACCESSWIRE / March 1, 2021 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage rare and unmet needs-focused gastroenterology company, announced today the Company has appointed Michael Rice to its board of directors. Mr. Rice is the president and co-founder of LifeSci Ad...